LYEL
Lyell Immunopharma Inc
9.80$
+1.7%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
Lyell Immunopharma Inc (LYEL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -34 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -38 | -41 | -42 | -38 | -35 | -47 | -55 | -34 | -29 | -32 | -39 | -34 | -133 | |
| 5.1 | 5.1 | 5.0 | 4.9 | 4.7 | 5.0 | 3.4 | 3.1 | 2.6 | 2.4 | 2.3 | 2.2 | 9.5 | |
| 11 | 8.5 | 9.2 | 8.3 | 7.6 | 8.1 | 6.0 | 5.0 | 5.2 | 26 | 4.3 | 4.5 | 40 | |
| 2.4 | 1.7 | -3.2 | -1.0 | 1.0 | 0.0 | -9.6 | -0.9 | -0.1 | 0.7 | -1.1 | 7.9 | 7.3 | |
| 0.2 | 0.0 | 0.0 | 0.3 | 0.1 | 0.0 | 0.2 | 0.2 | 0.1 | 0.3 | 0.1 | 0.3 | 0.7 | |
| 100 | -101 | 22 | 45 | 1.9 | 54 | 69 | 13 | 3.3 | -31 | 17 | 16 | 5.0 | |
| -0.2 | -0.1 | -0.1 | 0.8 | -0.7 | 36 | – | – | – | – | – | – | – | |
| -0.1 | 0.8 | 0.0 | 0.9 | 0.0 | 0.4 | 0.0 | 0.2 | 50 | 0.2 | 52 | 0.5 | 102 | |
| 62 | -141 | -20 | 7.8 | -33 | 5.3 | 15 | -22 | 25 | -63 | 31 | -18 | -26 | |
| -38 | -41 | -42 | -38 | -35 | -47 | -55 | -35 | -29 | -33 | -39 | -34 | -134 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.